CSPI Comments to FDA Re: Risk-Based Enforcement Approach to Homeopathic Drugs
![FDA Plans Tougher Policing of Homeopathic Drugs](/sites/default/files/styles/700x530/public/media/images/detail/homeopathic-drugs.jpg?h=73545cb6)
Homeopathic Drugs Could Benefit from Federal Oversight, Says CSPI
The group says it hopes the draft guidance signals enhanced federal attention on the homeopathic drug industry, now worth $3 billion dollars a year and growing quickly. It cites several examples of risky homeopathic products, including some linked to consumer injuries and deaths.
Topics